← Leaderboards
Papasani V Subbaiah
Rush University Medical Center
$6,546,593
Attributed
$8,758,001
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,758,001 · 8
VA$0 · 2
By mechanism
R01$6,713,007 · 3
R21$863,197 · 2
S10$439,654 · 1
R56$392,500 · 1
R41$349,643 · 1
I01$0 · 2
Top collaborators
- Irena Levitan5 shared
- Richard D Minshall5 shared
- Michael Cho4 shared
- Brian Thomas Layden1 shared
- Asha Anil Oroskar1 shared
Others in their field
Top investigators on “Phospholipids”
- Eugene W. St Clair · Duke University$24,182,181
- Valerian E Kagan · Wistar Institute$23,533,341
- Stanley J Opella · Wistar Institute$22,975,332
- Joel S. Bennett · University Of Pennsylvania$17,733,101
- George M. Carman · Rutgers The St Univ Of Nj New Brunswick$16,801,187
- Daniel E Kahne · Harvard University$16,303,151
Research focus
PhospholipidsAtherosclerosisBaseAlzheimer&AposLipidsLeadRisk FactorsHydrolysisPlasmaAnimalsCholesterolPropertyCholesterol EstersMembraneDietOxidized LipidCell MembraneEnvironmentAffectTissuesOmega-3 Fatty AcidsProteinsInflammationNutraceutical
Grant awards (35)
Novel strategy to enrich brain DHA through diet: Potential application for the prevention of Alzheimer's disease$0
I01 · FY2023 · VA · contact PI
Novel strategy to enrich brain DHA through diet: Potential application for the prevention of Alzheimer's disease$0
I01 · FY2022 · VA · contact PI
Novel strategy to enrich brain DHA through diet: Potential application for the prevention of Alzheimer's disease$0
I01 · FY2021 · VA · contact PI
A Novel DHA Treatment Approach for Alzheimer's Disease$349,643
R41 · FY2020 · AG
Novel strategy to enrich brain DHA through diet: Potential application for the prevention of Alzheimer's disease$0
I01 · FY2020 · VA · contact PI
Novel strategy to enrich brain DHA through diet: Potential application for the prevention of Alzheimer's disease$0
I01 · FY2019 · VA · contact PI
Impact of dyslipidemia on endothelial biomechanics$548,858
R01 · FY2016 · HL
Role of Membrane Modifications in the Bioactivities of Conjugated Linoleic Acids$0
I01 · FY2016 · VA · contact PI
Impact of dyslipidemia on endothelial biomechanics$540,625
R01 · FY2015 · HL
Molecular Form of Dietary DHA and its Bioavailability for the Brain$232,072
R21 · FY2015 · AT · contact PI
Role of Membrane Modifications in the Bioactivities of Conjugated Linoleic Acids$0
I01 · FY2015 · VA · contact PI
Impact of dyslipidemia on endothelial biomechanics$537,881
R01 · FY2014 · HL
Molecular Form of Dietary DHA and its Bioavailability for the Brain$199,375
R21 · FY2014 · AT · contact PI
Role of Membrane Modifications in the Bioactivities of Conjugated Linoleic Acids$0
I01 · FY2014 · VA · contact PI
Impact of dyslipidemia on endothelial biomechanics$522,513
R01 · FY2013 · HL
Role of Membrane Modifications in the Bioactivities of Conjugated Linoleic Acids$0
I01 · FY2013 · VA · contact PI
Impact of dyslipidemia on endothelial biomechanics$548,858
R01 · FY2012 · HL
Purchase of AB Sciex QTRAP 5500 System$439,654
S10 · FY2012 · OD · contact PI
Role of Sphingomyelin in Lipoprotein Metabolism$388,575
R01 · FY2012 · HL · contact PI
Role of Sphingomyelin in Lipoprotein Metabolism$392,500
R01 · FY2011 · HL · contact PI
Role of Sphingomyelin in Lipoprotein Metabolism$392,500
R01 · FY2010 · HL · contact PI
Role of Sphingomyelin in Lipoprotein Metabolism$392,500
R01 · FY2009 · HL · contact PI
Physiological Significance of Conjugated Double Bonds in Membrane Lipids$196,250
R21 · FY2009 · DK · contact PI
Role of Sphingomyelin in Lipoprotein Metabolism$392,500
R56 · FY2008 · HL · contact PI
Physiological Significance of Conjugated Double Bonds in Membrane Lipids$235,500
R21 · FY2008 · DK · contact PI
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM$340,555
R01 · FY2006 · HL · contact PI
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM$348,750
R01 · FY2005 · HL
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM$348,750
R01 · FY2004 · HL
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM$250,241
R01 · FY2003 · HL
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM$76,009
R01 · FY2003 · HL
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISM$351,250
R01 · FY2002 · HL
LCAT AND PATHOPHYSIOLOGY OF PHOSPHOLIPID SPECIES$126,705
R01 · FY2002 · HL
LCAT AND PATHOPHYSIOLOGY OF PHOSPHOLIPID SPECIES$124,000
R01 · FY2002 · HL
LCAT AND PATHOPHYSIOLOGY OF PHOSPHOLIPID SPECIES$244,530
R01 · FY2001 · HL
LCAT AND PATHOPHYSIOLOGY OF PHOSPHOLIPID SPECIES$237,407
R01 · FY2000 · HL